Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus InfectionLine K. Vibholm, Ole S. Søgaard, Jesper Falkesgaard Højen et al.|Clinical Infectious Diseases|2017Cited by 146
HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral ReboundRasmus Offersen, Galit Alter|Cell Reports|2020Cited by 30